Transcriptomic diversity across human populations reflects differential regulatory mechanisms. Allelic-imbalanced gene expression is a genetic regulatory mechanism that contributes to human phenotypic variation. To systematically investigate genome-wide allele-specific expression (ASE), we analyzed RNA-Seq data from European and African populations provided by the Geuvadis project. We identified 11 sites in 8 genes showing ASE in both Europeans and Africans, and 9 sites in 9 genes showing population-specific ASE, including both novel and known ASE signals. Notably, the top signal of differentiated ASE between inter-continental populations was observed in DNAJC15, of which the derived allele of rs12015, a single nucleotide polymorphism (SNP), showed significantly higher expression than did the ancestral allele specifically in European individuals. We identified a unique haplotype of DNAJC15, where a few SNPs highly differentiated between European and African populations were strongly linked to sites with high ASE. Among these, SNP rs17553284 affected the binding of several transcription factors as well as the genotype-dependent expression of DNAJC15. Therefore, we speculated that rs17553284 could be a regulatory causal variant that mediates the ASE of rs12015. We found several variations in ASE between intercontinental populations. The highly differentiated ASE genes identified here may implicate in the phenotypic variations among populations that are both evolutionarily and medically important.
Introduction
The genetic diversity of modern human populations is complex as a result of various factors acting on different temporal and spatial scales, including population migrations, mutation, genetic drift and selection (1) . It is therefore challenging to interpret the complex pattern of human genetic diversity with respect to phenotype (2) . However, it is possible to use gene expression patterns to convert cryptic genomic information into developmental, morphological and physiological phenotypes; the modification of gene expression through genetic variation profoundly affects individual phenotypes (3) .
The allele-specific expression (ASE) refers to the quantifiable variation in expression between two haplotypes of a diploid † These authors contributed equally to this work. individual. Such an allelic imbalance in gene expression is only quantifiable when the two haplotypes differ at a heterozygous site and the transcription originates primarily from a single allele. The complex ASE phenomenon could be resulted from a variety of biological mechanisms, such as alternative transcript splicing and disruption of the polyadenylation regulatory region, as well as epigenetic effects, including histone modification and DNA methylation (4) (5) (6) .
The recent availability of massively parallel DNA-and RNAsequencing technologies, as well as comprehensive bioinformatics approaches; now allow the quantification of ASE across the human genome. ASE analyses may pinpoint the causative and rare genetic variants associated with complex traits or diseases (7) as well as provide insights into the mechanistic role of functional single nucleotide polymorphisms (SNPs). Indeed, several genome-wide association studies (GWAS) for diseases have been interpreted based on the ability of a given genotype to modulate the transcriptional activity of the target gene in an allele-specific fashion (8) (9) (10) . In addition, ASE affects downstream molecular functions by changing the quantity as well as the quality of the encoded proteins (11) .
The discrete genetic ancestry of ethnically diverse human populations suggests the possible existence of populationspecific ASE; such ASE may be implicated in phenotypic distinctions. Previous studies have identified several genes significantly differentially expressed between individuals of European and African descent (12) (13) (14) . In addition, differences in the genomewide alternative splicing patterns and epigenetic trends between these two groups suggested that the ASE of these populations derived from different sources (15) (16) (17) (18) . However, the quantitative patterns of ASE across human populations have not been previously investigated.
Here, we estimated ASE heterogeneity and uniformity trends across European and African populations using mainly the publicly available data from the Geuvadis project. Besides, Human Genome Diversity Project (HGDP) and HapMap III project data used for additional validation and interpretation of the top differentiated ASE site. Our ASE-based comparative analyses across these populations may lead to a better understanding of the fundamental significance of ASE with respect to disease or selection relevant traits.
Results

General profile of ASE sites
We examined 224 562 SNPs after quality control (see 'Materials and Methods' section) for ASE based on allele-specific RNA-Seq read counts and mapping biases of Geuvadis samples (Supplementary Material, Table S5 ) from Castel et al. (19) . We calculated the number of ASE loci with read coverage !30 and FDR < 5% (see 'Materials and Methods' section). The complete list of identified ASE sites with high confidence in at least one individual in each population can be found in Additional files 1 & 2. The number of ASE sites per individual was much higher in the African populations than in the European populations (Table 1) , possibly because the genetic background of the African population was more heterogeneous. Further testing indicated that, indeed, the number of heterozygous SNPs (covered by !30 reads) and the number of ASE sites were significantly correlated across all individuals (Spearman correlation coefficient ¼ 0.81; P < 2.2 Â 10
À16
; Supplementary Material, Fig.  S1 ). To test the accuracy of our ASE detection, we compared our results with Allele-DB v2.1 (20) , which contains Geuvadis data.
After stringent quality control (see 'Materials and Methods' section), the Pearson correlation coefficient between reference ratios of the overlapped 72 513 ASE pairs was 0.97 (Supplementary Material, Fig. S2 ).
Functional categorization of ASE sites
We classified ASE sites into non-sense mediated decay (NMD) and missense variants for each African and European population based on Ensembl VEP (21) ( Table 1) . Approximately 40% of the ASE sites across all populations were found to be involved in NMD (Table 1) . We found that only $14% of ASE sites were expression quantitative trait loci (eQTLs, see 'Detection of eQTLs' section), while $18% of ASE sites were identified as missense SNPs.
We scanned all the detected ASE sites against NHGRI-EBI GWAS Catalog to further investigate their functional impact (https://www.ebi.ac.uk/gwas/) v1.0.1 (22) . The entire GWAS SNPs set been cataloged in genetic association with common diseases or traits with P < 1 Â 10 À5 was selected. This analysis inferred that European populations had few ASE sites specifically involved in skin color saturation and chronic lymphocytic leukemia phenotypes, while the African population had a specific ASE site associated with the ejection fraction phenotype in Trypanosoma cruzi seropositive individuals (23) (Supplementary Material, Table S1 ).
Shared ASE sites between African and European populations
Employing our newly developed statistic (ASES, see 'Materials and Methods' section), we identified 8 genes on several loci with similar ASE patterns in both African and European populations ( Table 2 ). Three of these ASE sites, (SNPs rs2549782, rs10954213 and rs705) were previously reported to be associated with expression of the ERAP2, IRF5 and SNRPN genes, respectively (24, 25) . Several additional ASE sites in ERAP2 gene (rs1056893, rs2548538, rs2255546 and rs2287988) exhibited similar ASE patterns across all populations. The clinical significance of ASE exhibiting variants at ERAP2 was previously reported (24) . We therefore hypothesize that the additional novel ASE sites identified here may also be bio-medically relevant.
Genetic differentiation of ASE sites between populations
A distinct clustering pattern of ASE sites was observed on a multiple-dimensional scale (MDS) plot comparing pairwise ASE distances between individuals of European and African populations; different European populations were quite uniform (Fig. 1A) . In this first analysis, we retained only the ASE sites Fig. S4 ) and implies that ASE patterns are distinct between intercontinental human populations.
Typically, ASE differences (ASEDs) between groups at a single locus are calculated by the difference in the proportion of ASE over all loci. However, this metric does not control for unequal sample sizes and is not applicable to multiple populations. Since the number of heterozygous individuals change across genomes, so these issues are critical. We, therefore developed a novel Table S2 ), which is consistent with our MDS plot (Fig. 1A) . Our genome-wide ASE differentiation analyses across both African and European populations recovered several loci with large differences in ASE (ASED ! 0.8; Fig. 1B -E). When we calculated pairwise ASEDs among populations, we found that the average ASED between European and African populations was 3.2%; ASED among European populations was only 0.6% (Supplementary Material, Table S3 ). This suggests that ASE differ among intercontinental populations and that most ASEDs are intercontinental rather than intracontinental. (Table 2) . We performed additional genetic and epigenetic analyses to interpret the possible biological scenarios responsible for these population-based highly differentiated ASE sites. Of all SNPs, rs12015 had the highest average ASE frequency (89%) across all European populations (CEU: 80%, GBR: 90%, FIN: 88% and TSI: 95%). ASE frequency was 0% for rs12015 in the African population (Table 3 ; Fig. 2B ). The rs12015 is located in the first exon of DNAJC15, and is non-synonymous with an ancestral 'G' and a derived 'A' allele; the glycine codon is changed to arginine during protein coding. Within heterozygous European individuals, the expression of derived allele-A was significantly higher than that of ancestral allele-G at this locus (Fig. 2C) . In addition, European individuals carrying allele-A overexpressed DNAJC15 in comparison to European individuals carrying allele-G (Fig. 2C) . However, neither the allelic dosage effect nor any imbalanced expression at this locus was observed in African individuals. In general, the rs12015 allelic dosage effect we found was consistent with the HapMap III samples (Fig. 2D) . The higher expression of allele-A at rs12015 SNP was also identified in heterozygous individuals of Eurasian origins (e.g. Pathan and Yakut) in the HGDP RNA-Seq data (Fig. 2B) .
Top differentiated ASE sites
The top differentiated ASE SNP (i.e. rs12015) in DNAJC15 was reported to be in correlation with nearby CpG island methylation variability in acute lymphoblastic leukemia patients (5). However, we found no significant methylation difference in DNAJC15 when we compared methylation level between European and African healthy individuals from the HapMap project (Supplementary Material, Fig. S6 ). This excluded the possibility of populationspecific methylation basis at the nearby CpG island caused highly differentiated ASE features at rs12015. In addition, although Fraser et al. (17) identified a considerable number of CpG sites with population-specific DNA methylation for CEU and YRI individuals, our reanalysis of their published data did not suggest that DNAJC15's nearby CpG islands are significantly different with respect to population-specific methylation.
Previous studies have suggested that genetic variation is a major cause of ASE (7, 26, 27) . However, our pairwise F ST recovered no significant differences in allele frequency at rs12015 between European and African populations . This suggested that genetic differences at the nearby linked loci could mediate the differentiated ASE signals and that these regulatory regions may harbor causal variants. To test this, we searched for significantly differentiated variants between populations at entire region of DNAJC15 and its flanking regions (100 kb upstream and downstream). By employing the linkage disequilibrium (LD) analysis, we found a total of 22 SNPs in strong linkage (r 2 > 0.9) with the target SNP (rs12015) in CEU, and observed no SNP in linkage with the target SNP in YRI with LD score > 0.6 (Table 4 ; Fig. 3 ). There were three SNPs out of these 22 showing the top 5% of the whole genome F ST between European and African groups (Table 4 ; Supplementary Material, Fig. S7D ). These three linked SNPs formed a unique Eurasian haplotype ( Fig. 3;  Supplementary Material, Fig. S8) ; SNP rs17553284 was identified as the pioneer locus in the construction of this unique haplotype (Fig. 3) . The rs17553284 was located in a CpG island at the 5 0 UTR of DNAJC15, and was strongly linked with rs12015 across all Europeans populations [LD (r 2 ) ¼1; Table 4 ]. In all European individuals, rs12015 allele-A always co-existed with rs17553284 allele-C; conversely, rs12015 allele-G always co-existed with rs17553284 allele-T. This pattern suggests a potential genetic interaction between rs12015 and rs17553284 SNPs.
We speculated that the binding activity of the allele-specific transcription factors (TFs) may drive a mechanism that influences ASE at the rs12015. The ePOSSUM tool (28) , which provides a reliable prediction based on experimentally confirmed TF binding was employed to assess the impact of TF binding at these linked SNPs. This analysis indicated that SNP rs17553284 influenced the binding activity of 13 known TFs (Supplementary Material, Table S4 ). Our analysis of the binding activity of downstream allele-specific TFs using the regulome database (29) suggested that the binding of several TFs (CEBPB, EBF1, MAX, PAX5, POU2F2, RUNX3, SP1 and YY1) was modulated by rs17553284 in lymphoblastoid cell lines. Our analysis also indicated that rs11618553 attenuates the binding activity of MAFK in human liver carcinoma cells (HepG2). We did not find any evidence that SNP rs17553846 affected binding activity of any TFs. Although no study so far has reported about DNAJC15's ASE behavior with respect to rs17553284 SNP's altering TF binding activity, we speculated that attenuation of the binding activity of multiple TFs by SNP rs17553284 might trigger a biological mechanism, eventually leading to the observed differences in ASE pattern in DNAJC15 in European and African populations.
When we analyzed the association between rs17553284 genotypes and DNAJC15 expression, we observed a genotypedependent expression pattern in one Eurasian population and two African populations (the Maasai people, from Kinyawa, Kenya and the Luhya people, from Webuye and Kenya). This pattern was absent in the YRI population, due to the complete absence of allele-T (Fig. 4A and D) . These results suggested that the regulatory mechanism at this locus was uniform across continental populations and that SNP rs17553284 is a casual variant triggering the observed differences in ASE pattern at rs12015 in DNAJC15 between European and African populations. Indeed, Battle et al. (26) reported an association between rs17553284 and the ASE of DNAJC15 in European individuals.
In addition to DNAJC15, several others genes showed population-specific ASE patterns based on our ASED statistic (Table 3 ). For example, the ASE of SERPINB10 was more predominant in European populations; this was correlated with a regulatory haplotype in human subjects (30) . Therefore, we speculated that regulatory loci with distinct population-wide genetic backgrounds might drive population-specific ASE signals. When the top population-specific ASE sites (Table 3) were scanned against the population-specific methylation data of Fraser et al. (17) , only two genes (i.e. IL18BP and RPL13) are found to have population-specific methylation patterns, possibly resulting in the observed ASEDs.
Discussion
The ASE phenomenon is responsible for human phenotypic variability and implicated in certain diseases (31) . ASE is considered a relatively common event among non-imprinted autosomal genes (32) . Previous studies have primarily focused on characterizing intrapopulation ASE and determining the association of these ASE events with certain diseases (5, 11, 26, 30) . In contrast, we quantified ASE variability within and among intercontinental human populations. Identifying unique ASE within and between populations provides additional insights into the functional roles of human genes.
The genome-wide, more ASE sites as found in the African population than in the European populations (Fig. 1) , likely due to the higher average heterozygosity of the African population (33; Supplementary Material, Fig. S1 ). However, the most highly differentiated ASE sites were found in Europeans (Table 3 ). The strong correlation between the ASE sites detected in our analysis and those reported in Allele-DB repository (Pearson correlation coefficient 0.97) indicated that the ASE identified in our analysis is consistent with the previous study (20) .
The functional annotation of ASE sites revealed a preponderance proportion of ASE sites as NMD ($40%). A previous study based on human cell line transcriptome predicated that most non-sense premature stop codon variants triggered NMD, rather than escape the NMD through an unknown mechanism (7). In contrast, a recent study in mice reported that $30% of these variants lead to marked reduction of expression of impaired alleles (34) . Therefore, NMD detection remains controversial. Investigation of ASE at NMD sites may lead to a better understanding of the mechanisms underlying NMD. The fraction of ASE variants identified as eQTLs matches with the previous study that reported 15-20% of eQTLs exhibiting ASE feature (34). The This means that traditional eQTLs analysis is not sufficient to capture ASE sites, especially in studies with small sample size (35) (36) (37) . The fraction of ASE site annotated as missense SNPs may reduce the expression of deleterious alleles through ASE. Natural selection shaped the genetic variation of human populations during their earliest settlements in different continental regions (38) (39) (40) . Previous studies have suggested that ASE differences between populations were influenced by natural selection (41, 42) . The frequency distribution of ASE QTL has also been reported to be consistent with predominantly purifying selection (41) . Our analysis was consistent with this suggestion: we showed that the SNPs linked to ASE sites in core promoters and others in regulatory regions were genetically different. The DNAJC15 gene encodes a mitochondrial methylation-controlled J protein (MCJ) that regulates the metabolic status of macrophage cells during the inflammatory response (43) . The MCJ modulator protein reduces mitochondrial metabolism during adaptation to metabolic stress conditions and plays an important role in the regulation of the macrophage response to infectious agents (44) . In a mouse macrophage model, DNAJC15 was shown to regulate gene expression independent of DNA methylation, providing additional evidence for the role of DNAJC15 in dynamic metabolic adaptation during infectious conditions (43) . Based on the known molecular functions of DNAJC15, the preponderance of ASE at this locus in Europeans could simply have resulted from selective pressures exerted by pathogens or dietary changes in new environments during early European settlement (45) . We used the iHS (46) and F ST statistics to look for evidence of natural selection throughout the DNAJC15 gene region, including the linked regulatory SNP. The iHS statistic identified only one SNP in DNAJC15 with an iHS score ! 2. However, F ST identified several SNPs in the CEU population with F ST scores above the genomewide top 5% F ST score (F ST > 0.19), including some SNPs linked to sites with high levels of ASE (e.g. rs12015; Supplementary Material, Fig. S7D ). Our analysis, therefore, identified some evidence for natural selection in the CEU population, but not in the YRI population (Supplementary Material, Fig. S7A-C) , supporting our hypothesis that natural selection might have shaped the different ASE patterns at DNAJC15 that we observed.
Conclusion
Despite the similar pattern of ASE among intercontinental populations, we identified several significant genome-wide differences in ASE between African and European populations, particularly in the gene DNAJC15. We hypothesized that the observed ASEDs across intercontinental populations might have been caused both by historically complex population demographics and by natural selection.
Materials and Methods
Data collection
We used genotype and RNA-Seq/microarray data from multiple projects, including the 1000 Genomes project (47) samples from Geuvadis (7), HGDP (48) and HapMap III (49; Supplementary Material, Table S5 ). All variant coordinates we used were based on the human reference genome NCBI build37/UCSC hg19.
Quality control
SNPs with a high missingness rate (>10%), with a low minor allele frequency (<1%) or in Hardy-Weinberg disequilibrium (P-value < 10 À6 ) were removed using PLINK v1.07 (50) . In order to exclude any sequencing errors, we only retained SNPs located in regions conforming to the 'strict' criteria of the 1000 Genomes Project.
Detection of eQTLs
We detected eQTLs in each population using a linear regression model, where gene expression was associated with SNPs after correction for gender, age and population sub-structure. Population sub-structure was adjusted by taking the top 10 principal components as covariates, as indicated by independent SNP analysis, after quality control with EIGENSTRAT v9003 (51, 52) . We performed this analysis using the package MatrixEQTL (53) in R (54).
Allelic bias estimation
We calculated allelic bias using the following equation: given a SNP with alleles A/G, the allelic bias for allele-A within a population is
where A i is the number of reads carrying allele-A for individual i and G i is the number of reads carrying allele-G for individual i. If the allelic bias of A is > 0, allele-A is overexpressed; if the allelic bias of A is < 0, allele-A is underexpressed. This statistic was only used for comparison of allelic expression bias at the top ASE site among worldwide populations, i.e. rs12015 (Fig. 2B) .
ASE detection
We used the allelic RNA-Seq read counts and mapping biases from Castel et al. (19) . To perform the binomial test, we set the mapping bias as the hypothesized probability of success and corrected the Pvalues using the FDR correction in R (54). A locus was considered ASE when the RNA-Seq read coverage was ! 30 and the FDR was < 5%.
ASE distance between individuals
ASE may only be detectable at heterozygous sites in RNA-Seq data. A previous study measured ASE distance between individuals as the proportion of non-shared ASE sites at shared heterozygous sites (19) . However, when there are few RNA-Seq reads at heterozygous sites, ASE cannot be reliably detected (55) . For this reason, we considered only those heterozygous sites with ! 30 RNA-Seq reads.
ASED calculation among populations
We developed a novel statistic to measure the ASED among populations. Our ASED statistic was derived from FST, which is a moment estimator of genetic difference among populations that accounts for unequal sample sizes (56) . Our statistic was defined as follows: suppose we have r populations, and for SNP k in population i there are n i heterozygous samples covered by at least 30 sequence reads. Let
The expectation and variance of X ij are calculated as follows:
where h denotes was the correlation coefficient, which measured relatedness of a pairwise ASE within a population relative to total relatedness, and p i represented the expected proportion of ASE in population i. p i which is given by
where the expectation and variance ofp i are
The expected proportion of ASE across all samples was p, which was defined as The observed mean square among populations (MSP) was defined as
with expectation
where n c ¼ 
Detection of ASE shared among populations
Common ASE across several populations could intuitively be calculated as 1-ASED. However, this calculation might return high values for rare ASE sites. For example, if the ASE proportion for one SNP was 0 in all populations, ASED would be 0 and 1-ASE would be 100, indicating that ASE commonality at these SNPs was 100%. This is obviously incorrect. Therefore, we included ASE proportions in our formula for calculating shared ASE (ASES) as follows:
where r is the population number and p i is the ASE proportion in population i.
Positive selection and LD estimation
The iHS statistic was used to detect positive selection; iHS is based on haplotypes under neutral drift that are unexpectedly long (46) . Standardized iHS scores were calculated for every SNP with minor allele frequency ! 5% using the rehh package (57) in R (54). We used Haploview (58) to perform the LD analysis of the CEU and YRI populations.
Supplementary Material
Supplementary Material is available at HMG online.
